What is Arvinas's EPS (diluted)?

Arvinas (ARVN) reported EPS (diluted) of -$0.90 in Q1 2026.

How has Arvinas's EPS (diluted) changed year-over-year?

Arvinas's EPS (diluted) decreased by 178.9% year-over-year, from $1.14 to -$0.90.

What is the long-term trend for Arvinas's EPS (diluted)?

Over 4 years (2021 to 2025), Arvinas's EPS (diluted) has grown at a -26.1% compound annual growth rate (CAGR), from -$3.82 to -$1.14.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Arvinas ARVN EPS (Diluted)

EPS (Diluted) at other companies

Nurix Therapeutics, Inc.NRIX

-$0.79-17.9%

Kymera TherapeuticsKYMR

-$0.71+13.4%

Relmada Therapeutics, Inc.RLMD

-$0.22+62.1%

Nuvectis Pharma, Inc.NVCT

-$0.26+3.7%

ArriVent BioPharma, Inc.AVBP

-$0.96+49.5%

ImmunomeIMNM

-$0.48+7.7%

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's EPS (diluted)?: Arvinas (ARVN) reported EPS (diluted) of -$0.90 in Q1 2026.
How has Arvinas's EPS (diluted) changed year-over-year?: Arvinas's EPS (diluted) decreased by 178.9% year-over-year, from $1.14 to -$0.90.
What is the long-term trend for Arvinas's EPS (diluted)?: Over 4 years (2021 to 2025), Arvinas's EPS (diluted) has grown at a -26.1% compound annual growth rate (CAGR), from -$3.82 to -$1.14.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.